TRDA
Entrada Therapeutics, Inc. · Healthcare
President and COO Nathan J Dowden sold $441K of Entrada Therapeutics, Inc.
Sold$440,801
$16.27Price
27,097Shares
−17%Stake
What TRDA did after the filing
- The stock from Wed, Aug 21 open, $16.93
- −2.9%
- S&P 500, same days
- +1.7%
Measured over 30 trading days, to the Oct 3 close.
Traded Fri, Aug 16. Filed Tue, Aug 20, 4:33 PM ET, after the close. Returns use the Aug 21 open and the Oct 3 close. Not investment advice.